The First Amendment and Off-Label Enforcement: Understanding the Impact of the Caronia/Amarin/Pacira/ Vascular Solutions Cases on the Medical Device and FDA-Related Industries

The First Amendment and Off-Label Enforcement: Understanding the Impact of the Caronia/Amarin/Pacira/ Vascular Solutions Cases on the Medical Device and FDA-Related Industries - July 2016
by Mona Patel, Partner at Covington & Burling LLP, Michael Pauze, Partner at King & Spalding LLP